Skip to main content
MMS $55.28 -1.39%
MMS logo

MMS · Maximus, Inc.

Track MMS — free
$55.28 -0.78 (-1.39%) At close · Aug 14
Market Cap
$2.89B
Shares
52.36M
All earnings calls

Earnings call · FY2026 Q3

Q3 FY26 Earnings Conference Call

Q3 FY26 Earnings Conference Call

Concluded Aug 6, 2026 Audio replay
Aug 6, 2026 27:00 25 turns
Period
FY2026 Q3
Runtime
27:00
Sources
5 artifacts

Executive readout · one minute

What matters this quarter

Maximus reported Q3 FY26 adjusted EPS of $2.22 on $1.28B revenue but lowered full-year adjusted EPS guidance to $7.90-$8.20 due to a temporary customer-directed contract modification, updated free cash flow guidance to $425-$475M, and reiterated revenue guidance of $5.2B-$5.35B.

SNAP and payment accuracy 56 Defense and national security market 14 Medicaid community engagement / work requirements 12 Capital allocation and M&A 10 Federal procurement delays and book-to-bill 8 AI adoption and capabilities 7

Management tone

Balanced

Net tone +10 · moderate hedging

Grounding quotes
  • “we continue to view the underlying demand environment as constructive, with the latest total value of opportunities remaining substantial and supporting our long-term growth objectives”
  • “we believe that the demand for community engagement solutions remains positive, and as states continue to evaluate options, we remain optimistic that Maximus has an important role to play”
  • “Opportunities are maturing more slowly”
  • “There's little doubt that the complexity of the recently released interim final rule by CMS has created additional uncertainty for states as they determine how best to operationalize compliance requirements”

Forward guidance

6 guided metrics

Management's latest ranges and targets are included below.

Research coverage

5 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $1.28B -5.1% YoY
Diluted EPS $1.95 +4.8% YoY
Gross margin 27.3% +0.6 pp YoY
Net income $103.59M -2.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Adjusted diluted EPS of $2.22 beat prior-year $2.16, with adjusted EBITDA margin expanding to 15.0% from 14.7%
  • U.S. Federal Services segment operating margin expanded to 18.6% from 18.1% on productivity and technology-enabled efficiencies
  • FY26 revenue guidance of $5.2B-$5.35B was reiterated, with management noting Q3 revenue was in line with expectations
  • $245M collected since July 1 from a large federal customer, supporting DSO dropping below 70 by end of September and updated free cash flow guidance of $425M-$475M

Risks & pressure points

  • FY26 adjusted EPS guidance was lowered to $7.90-$8.20 due to a temporary customer-directed contractual modification on a major federal program effective July 1-December 31, 2026
  • U.S. Federal Services full-year operating margin guidance was lowered to 16.5%-17.0% range because of the contract modification
  • FY26 adjusted EBITDA margin guidance of approximately 13.7% reflects the contract modification impact
  • Q3 revenue declined to $1.28B from $1.35B, though the prior year benefited from non-recurring disaster and clinical volume activity

Key moments

Jump directly to management's words in the synchronized transcript.

Forward guidance

From the 8-K filed Aug 6, 2026.

Metric Guided
Revenue
fiscal year 2026
$5.2B – $5.35B
Adjusted diluted earnings per share
fiscal year 2026
$7.90 – $8.20
Adjusted EBITDA margin
fiscal year 2026
13.7%
Full-year operating margin for the U.S. Federal Services Segment
fiscal year 2026
16.5% – 17%
Free cash flow
fiscal year 2026
$425M – $475M
Full-year fiscal 2026 operating margin for the U.S. Services Seg
fiscal year 2026
9.5% – 10%

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

U.S. Federal Services$720.99M -5.3% YoY
US Services$418.23M -4.9% YoY
Outside the United States$139.75M -5.2% YoY

Capital returned

Buybacks · derived
$49.92M
Shares repurchased
752,700
Dividend / share
$0.33
Full-screen source Call document